MAPK8 and Alzheimer disease: Mitogen-activated protein kinase (MAPK) pathways, including the extracellular signal-regulated kinase 1/2 (ERK), c- Jun N-terminal kinase (JNK), and P38 kinase (P38) pathways, have been shown to influence AD development and progression [146,147].